FAM90A27P: A Potential Drug Target and Biomarker for Family with Sequence Similarity 90 Member A27

Target Name: FAM90A27P

NCBI ID: G646508

FAM90A27P

Other Name(s): Family with sequence similarity 90 member A27, pseudogene | family with sequence similarity 90 member A27, pseudogene

FAM90A27P: A Potential Drug Target and Biomarker for Family with Sequence Similarity 90 Member A27

Sequence similarity 90 member A27 (FAM90A27) is a protein that plays a crucial role in various cellular processes, including cell adhesion, migration, and invasion. It is a member of the FAM90A family, which is known for its involvement in various cellular processes, including cell signaling, DNA replication, and repair. The FAM90A27 protein has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

FAM90A27P: A Potential Drug Target

The FAM90A27 protein is known to play a role in several cellular processes that are associated with the development and progression of various diseases. One of the most significant functions of FAM90A27 is its role in cell adhesion and migration. FAM90A27 is involved in the formation of tight junctions, which are essential for maintaining tissue structure and function. It is also involved in the regulation of cell migration, which is critical for the development of tissues and organs during development and regeneration.

FAM90A27 has also been shown to play a role in cell signaling. It is involved in the regulation of several signaling pathways, including the TGF-β pathway, which is critical for cell growth, differentiation, and survival. The TGF-β pathway is known to be involved in the development and progression of many diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

FAM90A27 has also been shown to play a role in DNA replication and repair. It is involved in the regulation of DNA replication, which is critical for the maintenance of genetic diversity and the development of new tissues during cell division. FAM90A27 has also been shown to play a role in the regulation of DNA repair, which is critical for the correction of genetic mutations that can occur during DNA replication.

FAM90A27 has been shown to be involved in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that FAM90A27 is involved in the development and progression of colon cancer. Additionally, FAM90A27 has been shown to be involved in the development and progression of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

FAM90A27 may also be a potential biomarker for these diseases. Studies have shown that FAM90A27 is expressed in the brains of individuals with Alzheimer's disease and Parkinson's disease. Additionally, FAM90A27 has been shown to be involved in the regulation of several cellular processes that are associated with the development and progression of these diseases.

FAM90A27P: A Potential Biomarker

FAM90A27 has also been shown to be involved in the regulation of several cellular processes that are associated with the development and progression of various diseases. One of the most significant functions of FAM90A27 is its role in cell adhesion and migration. FAM90A27 is involved in the formation of tight junctions, which are essential for maintaining tissue structure and function. It is also involved in the regulation of cell migration, which is critical for the development of tissues and organs during development and regeneration.

FAM90A27 has also been shown to play a role in cell signaling. It is involved in the regulation of several signaling pathways, including the TGF-β pathway, which is critical for

Protein Name: Family With Sequence Similarity 90 Member A27, Pseudogene

The "FAM90A27P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM90A27P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets